Calamos Advisors LLC Raises Stake in Humana Inc. $HUM

Calamos Advisors LLC lifted its stake in Humana Inc. (NYSE:HUM) by 4.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 37,245 shares of the insurance provider’s stock after purchasing an additional 1,735 shares during the period. Calamos Advisors LLC’s holdings in Humana were worth $6,458,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in Humana by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock valued at $3,652,890,000 after buying an additional 106,030 shares in the last quarter. Capital International Investors grew its stake in Humana by 113.9% in the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after acquiring an additional 3,097,571 shares in the last quarter. Pzena Investment Management LLC increased its position in shares of Humana by 34.3% during the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after acquiring an additional 1,398,774 shares during the period. State Street Corp increased its position in shares of Humana by 1.8% during the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after acquiring an additional 97,211 shares during the period. Finally, Massachusetts Financial Services Co. MA raised its stake in shares of Humana by 28.9% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after acquiring an additional 1,008,514 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Price Performance

NYSE HUM opened at $406.70 on Wednesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The firm’s 50 day moving average price is $345.52 and its 200-day moving average price is $257.26. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $415.00. The company has a market cap of $48.83 billion, a PE ratio of 43.50, a P/E/G ratio of 2.31 and a beta of 0.71.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. Humana’s revenue was up 23.5% compared to the same quarter last year. During the same period last year, the company posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts forecast that Humana Inc. will post 9.03 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently issued reports on HUM. Oppenheimer upgraded Humana from an “outperform” rating to an “outperform” rating in a report on Wednesday, May 20th. TD Cowen raised their price objective on Humana from $211.00 to $350.00 and gave the stock a “hold” rating in a report on Tuesday. Evercore lifted their target price on Humana from $250.00 to $370.00 in a research report on Thursday, June 11th. Wells Fargo & Company upgraded Humana from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $227.00 to $502.00 in a report on Monday. Finally, Royal Bank Of Canada increased their price target on Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, sixteen have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $325.87.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.